• Syed Nizam Shah, Sadeq Wasil Al-Dandan, Muhammad Shuja, Ali Balbaid, Mohammad Bashir, and Musa Alharbi.
• From the Department of Pediatric Hematology and Oncology, King Fahad Medical City, Riyadh, Saudi Arabia.
• Ann Saudi Med. 2020 Nov 1; 40 (6): 482-490.

BackgroundThere is limited data from Saudi Arabia on the demographic characteristics, outcomes and effectiveness of different treatment modalities in children with intracranial ependymoma.ObjectiveStudy the characteristics of pediatric ependymoma and outcomes of treatment modalities in Saudi Arabia.DesignRetrospective.SettingTertiary care center.Patients And MethodsChildren with intracranial ependymoma who were younger than 14 years of age and treated between 2006 and 2015 were included in the study. Patients with prior radiation, chemo-therapy, or surgical resection at other centers were excluded.Main Outcome MeasuresKaplan-Meier survival curves were used to estimate the event-free (EFS) and overall survival (OS) rates of the patients.Sample Size22.ResultsOf the 22 children, 4 (18.2%) were less than three years old. All intracranial ependymomas had upfront surgical resection of the primary tumor. Gross total resection was achievable in 9 (42.9%) cases and subtotal resection in another 9 (42.9%). Near-total resection was done in 3 (14.3%) cases. Median time from surgery to start of radiotherapy was 62 days. RT was given to 17 (77.3%) patients. Both mean and median RT dose was 55.8 Gy. Only 5 (22.7%) of the children received chemotherapy. The median duration of follow-up was 5.38 years and the median time for EFS was 2.27 years. The cumulative OS rate of the study was 44.5%. The cumulative EFS survival rate of the study was 18.6%. Among demographic, pathological, radiological features, none had a statistically significant effect on the survival.ConclusionsThe outcomes are comparable to those reported by international investigators for similar populations. Further improvements can be achieved by avoiding delays in radiation therapy and adding molecular staging.LimitationsThe limited number of cases, retrospective nature, lack of molecular biology and size of the tumors.Conflict Of InterestNone.

20 keywords...

hide…